Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fu... (operating costs and expenses ...)

Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals

Date:2/9/2009

operating costs and expenses 270.6 294.9 1,143.5 1,022.8 ----- ----- ------- ------ Operating income 115.1 74.6 298.6 272.4 ----- ---- ----- ----- Non-operating (income) expense Interest income (1.4) (3.3) (10.0) (14.4) Interest expense 13.1 10.4 47.6 49.3 Other, net 2.8 3.2 9.1 (55.2) --- --- --- ------ Total non-operating expense (income) 14.5 10.3 46.7 (20.3) ---- ---- ---- ------ Earnings from continuing operations before income taxes 100.6 64.3 251.9 292.7 Income taxes 23.4 19.5 57.9 83.0 ---- ---- ---- ---- Earnings from continuing operations 77.2 44.8 194.0 209.7 Earnings from discontinued operations, net of tax - - - 1.6 ---- ---- ---- ---- Net earnings $77.2 $44.8 $194.0 $211.3 ===== ===== ====== ====== Basic earnings per share Continuing operations $1.22 $0.71 $3.08 $3.35 Discontinued operations - - - 0.03 ---- ---- ---- ---- Basic earnings per share $1.22 $0.71 $3.08 $3.38 ===== =====

SOURCE Beckman Coulter - IR
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33
Related biology technology :

1. Beckman Coulter to Present at the Bear Stearns Healthcare Conference
2. Beckman Coulter to Present at the UBS Global Life Sciences Conference
3. Beckman Coulter Announces Third Quarter 2007 Earnings to Be Released on Tuesday, October 30, 2007 Before Market Opens
4. Beckman Coulter Declares Quarterly Dividend
5. Beckman Coulter Announces Third Quarter 2007 Results
6. Beckman Coulter to Present at the 19th Annual Piper Jaffray Healthcare Conference
7. Beckman Coulter to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
8. Beckman Coulter to Acquire Exclusive Rights to Break-Through Technologies
9. Beckman Coulter Elects AMN Healthcare Executive to Board of Directors
10. Beckman Coulter to Present at the JPMorgan Healthcare Conference
11. AcroMetrix Signs Development and Supply Agreement With Beckman Coulter Inc. for Molecular Quality Control Standards

Post Your Comments:

(Date:11/6/2009)... 6 Myriant Technologies LLC ("Myri...ufacturer of renewable bio-chemicals, Uhde Corpor...ider Uhde GmbH, one of the world,s leading enginee...liance for the engineering, procurement & cons... plants based on renewable feedstocks. The execut...

(Date:11/6/2009)...Nov. 6 ,, 3Q09 Cor...Qutenza(TM) E.U. Marketing Authorization to Astell...in commercial readiness activities Expanded manag...arketing; and Director, Commercial Operations App...d Audit Committee chairman , Upcoming 2009 ...

(Date:11/6/2009)...Newswire-FirstCall/ - Oncolytics Biotech Inc. (TSX... today announced updated results from a Phase II s...arcomas metastatic to the lung in a poster present...y Society Meeting held in Miami Beach, Florida, fr...ntitled "A Phase II Study of Intravenous REOLYSIN ...

(Date:11/6/2009)... The agenda for Arrowhead’s 2010 Personalize...o take place on February 22-24, 2010 in Philadelph...ce we will highlight key issues in forming partner...experiences. , Minneapoli...rrowhead’s 2010 Personalized Medicine Partn...

[0] Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants [0] NeurogesX Reports Third Quarter 2009 Results [0] Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting [0] Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference

...ecklenburg region,certainly has not been immune to...unty, the NC Free Clinic Association has seen thei...ally Gilbert, the creator of,Charlotte,s premier h...ng Expo &,Symposium, wants to do something abo...thy lifestyle. But that scenario is,becoming incre...

...mprises Leading Sector Investors Clarus Ventures, ... , Heptares Therapeutics Ltd, the drug discove...upled receptors (GPCRs), announces today it has ra...ce in a successful Series A,private round from thr...Clarus Ventures led the syndicate, which includes ...

...l Academy of Sciences (NAS) congressionally mandat...ciencies in the nation,s forensic science system a...report also calls for the development of accredita...oficiency testing, certification and a code of eth.... , , The report notes that the American Board o...

Other Biology Technology:Charlotte Anti-Aging Expo & Symposium Supports Free Clinics 2 Heptares Secures GBP21 Million in Series A Fund Raising to Accelerate Development of Pipeline of Small Molecules Against High-Value GPCR Drug Targets 2 Heptares Secures GBP21 Million in Series A Fund Raising to Accelerate Development of Pipeline of Small Molecules Against High-Value GPCR Drug Targets 3 Heptares Secures GBP21 Million in Series A Fund Raising to Accelerate Development of Pipeline of Small Molecules Against High-Value GPCR Drug Targets 4 Heptares Secures GBP21 Million in Series A Fund Raising to Accelerate Development of Pipeline of Small Molecules Against High-Value GPCR Drug Targets 5 Strengthening Forensic Toxicology in the United States: The American Board of Forensic Toxicology Response to the National Academy of Sciences Recommendations 2

Charlotte Anti-Aging Expo & Symposium Supports Free Clinics Heptares Secures GBP21 Million in Series A Fund Raising to Accelerate Development of Pipeline of Small Molecules Against High-Value GPCR Drug Targets Strengthening Forensic Toxicology in the United States: The American Board of Forensic Toxicology Response to the National Academy of Sciences Recommendations

(Date:11/4/2009)...,, NEW YORK, Oct. 27 Global Rai...mpany and advanced R&D laboratory, today annou...e and is prepared to actively commercialize its su...dge biometric security offerings. ,, During the...llions of dollars to develop and deploy a series o...

(Date:11/4/2009)...,, CARLSBAD, Calif., Nov. 4 Gen...hat William Brody, M.D., Ph.D., has joined its Boa...idential Chair of the Salk Institute, is an acclai...ior to joining the Salk Institute, Dr. Brody serve...e is a member of the National Academy of Engineeri...

(Date:11/3/2009)... MADISON, WI, NOVEMBER 4, 2009 -- The world,s g...y among grape variety, human input, and something ...e vineyard site, soil, and climate. , Experts ...nce in a symposium on Wednesday, Nov. 4 in Pittsbu...ll be presented in two parts at the 2009 Annual Me...

Breaking Biology News(10 mins):Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2 Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3 Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2 Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3 Great wines come from great soils 2 New MedPredict Report Reveals Top Alzheimers Experts Insights on Diagnostics and Treatments in Development Pipeline 12601 1 New MedPredict Report Reveals Top Alzheimers Experts Insights on Diagnostics and Treatments in Development Pipeline 12601 2 Healthcare Travel Congress 2009 3A Experts Worldwide Convene in Singapore For Regional Conference on Medical Tourism 48752 1 Healthcare Travel Congress 2009 3A Experts Worldwide Convene in Singapore For Regional Conference on Medical Tourism 48752 2 Healthcare Travel Congress 2009 3A Experts Worldwide Convene in Singapore For Regional Conference on Medical Tourism 48752 3 Preparing the Americas 3A The Outlook for 2009s Emergency Threats 48748 1 Preparing the Americas 3A The Outlook for 2009s Emergency Threats 48748 2

[0] Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality [0] Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors [0] Great wines come from great soils

...rch team has found a new gene associated with the ...utation was specific to a rare form of epilepsy, t...overall epilepsy treatment. , The findings, which...ifferent countries, appear in the Nov. 7 issue of ...ilepsy, nerve cells in the brain signal abnormally...

...le flower per stalk while each stem of a tomato pl...n a new study, published in this week,s issue of t... Lippman and colleagues identify a genetic mechani... the Solanaceae (nightshade) family of plants that...o, petunia, and deadly nightshades. Manipulation o...

...te scientist and economist Jae Edmonds will speak ...re and sequestration in climate stabilization in t...l Conference on Greenhouse Gas Technologies. He is...ent of Energy,s Pacific Northwest National Laborat...the greenhouse gas and carbon management challenge...

Other Biology News:International team discovers gene associated with epilepsy 2 A big bunch of tomatoes? 2 PNNL leadership in carbon sequestration featured at international conference 2

International team discovers gene associated with epilepsy A big bunch of tomatoes?PNNL leadership in carbon sequestration featured at international conference

Xylanase Fluorometric (Blue) Assay Kit, EnzChek® from Molecular Probes (Invitrogen)

Goat Anti-Human p27 KIP 1 Polyclonal Antibody, Unconjugated from Abcam

Rabbit Anti-Defender against cell death 1 Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.

Goat Anti-Wnt-1 (G-19) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.

Biology Products:

Xylanase Fluorometric (Blue) Assay Kit, EnzChek® from Molecular Probes (Invitrogen)Goat Anti-Human p27 KIP 1 Polyclonal Antibody, Unconjugated from Abcam Rabbit Anti-Defender against cell death 1 Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.Goat Anti-Wnt-1 (G-19) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.

Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fu...(operating costs and expenses ...)